Dr. Caesar K. Tin-U, MD

  • Sugarland, TX
  • Medical oncologist
NPI1609814615PAC ID2163480963
Medicare services, 2024
10,956
Medicare patients, 2024
268
Part D claims, 2024
510
Publications
3
Clinical trials
2
Practice address
1350 1 Colony Blvd, Sugarland, TX 77479
Practice phone
Call (972) 997-8000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Texas Oncology PA

Sugarland, Texas

See all 6 affiliations

Find Dr. Tin-U's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Caesar K. Tin-U is a medical oncologist in Sugarland, Texas

Dr. Tin-U practices at Texas Oncology PA in Sugarland, Texas.

Dr. Tin-U's NPI, 1609814615, was assigned on June 2, 2006. Dr. Tin-U graduated from University Institute of Medicine 1 in 1985. Dr. Tin-U holds Texas license K8526.

NPI and contact details
Medicare PAC ID
2163480963
NPI enumeration date
June 2, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(972) 997-8000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
67
Medical school graduation
1985

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Caesar K. Tin-U practices at Texas Oncology PA in Sugarland, Texas

Dr. Tin-U's primary practice is Texas Oncology PA, at 1350 1 Colony Blvd, Sugarland, TX 77479 in Fort Bend County. The practice phone is (972) 997-8000.

  • Texas Oncology PA
    1350 1 Colony Blvd, Sugarland, TX 77479 · Fort Bend CountyPhone(972) 997-8000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Caesar K. Tin-U is affiliated with 5 sites of care and 1 medical group

Dr. Tin-U's primary practice is Texas Oncology PA in Sugarland, Texas. Dr. Tin-U is also affiliated with Houston Methodist Sugar Land Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Tin-U to 2 more hospitals and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Tin-U

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Caesar K. Tin-U's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tin-U practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Texas Oncology PAAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Tin-U practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Caesar K. Tin-U is one of 484 medical oncologists in Texas

Medical oncology is Dr. Tin-U's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Tin-U is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Tin-U's licenses on file in 2 states: Texas and Pennsylvania.

Specialties and state licenses

  • Medical oncology, TexasPrimaryLicense K8526 · 1999 to 2026 · taxonomy 207RX0202X
  • Pennsylvania license1993 to 2016

Clinical focus

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Tin-U treats.

Medical oncologists near Dr. Tin-U

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

484medical oncologists in Texas
7medical oncologists in Sugarland

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Caesar K. Tin-U billed Medicare for 10,956 services in 2024

CMS data shows 10,956 Medicare services from Dr. Tin-U across 28 procedure codes in 2024, for 268 Medicare patients. Medicare paid $91,459 for them.

Medicare services, 202410,956
Medicare patients268
Paid by Medicare$91,459
Procedure codes28

Dr. Tin-U's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 9,4972024: 6,58031%
Other services
2023: 4,0202024: 2,71732%
Tests and treatments
2023: 6672024: 6853%
Office and hospital visits
2023: 3582024: 3551%
Surgery
2023: 3262024: 28513%
Lab and pathology
2023: 3392024: 26223%
Imaging
2023: 712024: 721%

Where Dr. Tin-U's Medicare services took place, 2024

  • In an office10,80699%
  • In a facility1501%

Dr. Tin-U compared with the Texas median for medical oncologists, 2024

  • Dr. Tin-U
  • Texas median
Medicare services
10,956vs 73614.9 times
Medicare patients
268vs 20034% above
Part D claims
354vs 3346% above

Medians across 448 medical oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Tin-U's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Tin-U

Need commercial claims for Dr. Tin-U?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tin-U and other medical oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Caesar K. Tin-U treated 268 Medicare patients in 2024, average age 74

CMS counts 268 Medicare patients who saw Dr. Tin-U in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tin-U's median patient age at 67, with 64% women.

Medicare patients, 2024268
Average age74
Average risk score2.35
Also on Medicaid18%

Dr. Tin-U's Medicare patients by age, 2024

Dr. Tin-U's Medicare patients by sex, 2024

  • Women13651%
  • Men13249%

Chronic conditions among Dr. Tin-U's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer48%
  4. Arthritis46%
  5. Chronic kidney disease41%
  6. Diabetes40%
  7. Ischemic heart disease40%
  8. Heart failure34%

Share of Medicare patients with each condition. A patient can have several.

Dr. Tin-U's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women64%
  • Men35%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Caesar K. Tin-U wrote 510 Medicare Part D claims in 2024

In 2024, Dr. Tin-U wrote 510 Medicare Part D claims for 108 patients. 59% of them were for generic drugs. CMS names the drug for 354 of them, across 15 drugs with 11 or more claims each, at $1,228,824 in total drug cost. In 2023, CMS named 390 claims across 17 drugs.

Part D claims, 2024510
Drugs named by CMS15
Total drug cost$1.2M
Part D patients108

Dr. Tin-U's Part D claims by kind of drug, 2024

  • Generic303 claims59%
  • Brand-name207 claims41%

Dr. Tin-U's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Tin-U's Part D claims, 2024

  • Opioids13%65 of 510 claims
  • Antibiotics3%15 of 510 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3902024: 3549%

Drugs named by CMS: 15 in 2024, 17 in 2023.

See all prescribing by Dr. Tin-U

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Caesar K. Tin-U scored 85 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Tin-U for performance year 2024, reported through an alternative payment model (APM). Dr. Tin-U accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Tin-U's MIPS scores, performance year 2024

  • 85of 100Final score
  • 67.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Tin-U by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Caesar K. Tin-U has 3 publications on record

Dmand AI links 3 papers to Dr. Tin-U in 2005. The most frequent topics are Breast Neoplasms, Receptors, Retinoic Acid and Retinoids. Dr. Tin-U's most frequent co-authors are Powel H. Brown, PhD and Rammurti Kamble, MD.

Papers3

Topics Dr. Tin-U writes about most

  • Breast Neoplasms
  • Receptors, Retinoic Acid
  • Retinoids

Dr. Tin-U's most frequent co-authors

Recent publications by Dr. Tin-U

See all 3 publications and co-authors

See who Dr. Tin-U researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tin-U works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Caesar K. Tin-U has worked on 2 clinical trials

Dmand AI links Dr. Tin-U to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Breast Neoplasms and Breast Diseases.

Conditions in Dr. Tin-U's trials

  • Adenocarcinoma of Lung
  • Breast Neoplasms
  • Breast Diseases
  • Carcinoma, Non-Small-Cell Lung

Investigators on the most trials with Dr. Tin-U

Recent clinical trials with Dr. Tin-U

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Caesar K. Tin-U received $8,214 in industry payments from 2016 to 2025

CMS Open Payments shows 97 general payments to Dr. Tin-U from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Janssen Pharmaceuticals, Inc paid the most, $4,880.

General payments to Dr. Tin-U by program year, 2016 to 2025

General payments to Dr. Tin-U by kind, 2016 to 2025

$8.2Kin total
  • Consulting fees$3,53543%
  • Food and beverage$2,69933%
  • Travel and lodging$1,60620%
  • Education$3745%

Companies that paid Dr. Tin-U the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Tin-U

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Caesar K. Tin-U has 1 award and honors on record

Dmand AI lists 1 award for Dr. Tin-U, most recently CMS Stage 1 2012 in 2012.

Awards and honors for Dr. Tin-U

  1. 2012
    • CMS Stage 1 2012

Source: Dmand AI Professional Profile Data

Dr. Caesar K. Tin-U graduated from University Institute of Medicine 1

Dr. Tin-U graduated from University Institute of Medicine 1 in 1985. Dr. Tin-U is a member of ACP, ASCO, ASH and TMA.

  1. Medical schoolUniversity Institute of Medicine 1
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Caesar K. Tin-U accepts plans from 23 insurance carriers

Dr. Tin-U is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.

Plan types Dr. Tin-U accepts, by number of carriers

  1. PPO14
  2. HMO13
  3. Medicare10
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Caesar K. Tin-U's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Caesar K. Tin-U

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Caesar K. Tin-U's NPI number?

Dr. Caesar K. Tin-U's NPI number is 1609814615. It was assigned on June 2, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Caesar K. Tin-U?

Dr. Caesar K. Tin-U is a medical oncologist in Sugarland, Texas. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Caesar K. Tin-U practice?

Dr. Tin-U practices at 1350 1 Colony Blvd, Sugarland, TX 77479. Dr. Tin-U's primary practice is Texas Oncology PA in Sugarland, Texas. Dmand AI also links Dr. Tin-U to 2 hospitals and 1 group practice or clinic.

What is Dr. Caesar K. Tin-U's office phone number?

The practice phone on file for Dr. Tin-U is (972) 997-8000.

What is Dr. Caesar K. Tin-U's medical license number?

Dr. Tin-U holds Texas license K8526, one of the licenses on file in 2 states.

Which states has Dr. Caesar K. Tin-U been licensed in?

Dmand AI has state licenses on file for Dr. Tin-U in Texas (1999 to 2026) and Pennsylvania (1993 to 2016).

Which hospitals is Dr. Caesar K. Tin-U affiliated with?

Dr. Tin-U is affiliated with Houston Methodist Sugar Land Hospital. Dmand AI links Dr. Tin-U to 2 more hospitals.

What medical group is Dr. Caesar K. Tin-U part of?

Dr. Tin-U is linked to Texas Oncology.

Does Dr. Caesar K. Tin-U accept Medicare?

Yes. CMS data shows Dr. Tin-U billed Medicare for 10,956 services in 2024, and Dr. Tin-U accepts Medicare assignment.

What is Dr. Caesar K. Tin-U's MIPS score?

Dr. Tin-U's MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Caesar K. Tin-U see?

CMS counts 268 Medicare patients who saw Dr. Tin-U in 2024, with an average age of 74.

Is Dr. Caesar K. Tin-U board certified?

Yes. Dr. Tin-U is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Caesar K. Tin-U bill to Medicare?

In 2024, Dr. Tin-U's most billed Medicare services were injected or infused drug (J1453), medicare temporary code (Q9967) and injected or infused drug (J1100).

Where did Dr. Caesar K. Tin-U go to medical school?

Dr. Tin-U graduated from University Institute of Medicine 1 in 1985.

What drugs does Dr. Caesar K. Tin-U prescribe most?

In 2024 Medicare Part D data, Dr. Tin-U's most prescribed drugs by claims were Eliquis, Hydrocodone-Acetaminophen and Xarelto.

Has Dr. Caesar K. Tin-U received payments from drug or device companies?

CMS Open Payments shows $8,214 in general payments to Dr. Tin-U from 25 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Caesar K. Tin-U been practicing?

Dr. Tin-U graduated from medical school in 1985, 41 years ago.

Does Dr. Caesar K. Tin-U do research?

Dmand AI links 3 publications to Dr. Tin-U. Dr. Tin-U has worked on 2 clinical trials.

Who does Dr. Caesar K. Tin-U publish with?

Dr. Tin-U's most frequent co-authors are Powel H. Brown, PhD (2 shared papers) and Rammurti Kamble, MD (1 shared paper).

What insurance does Dr. Caesar K. Tin-U accept?

Dr. Tin-U is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)